Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-arrestin Antagonist Activity

The atypical chemokine receptor CXCR7 has been studied in various disease settings including immunological diseases and heart disease. Efforts to elucidate the role of CXCR7 have been limited by th...